Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma LtdfiledCriticalNatco Pharma Ltd
Priority to CO10086534ApriorityCriticalpatent/CO6300947A2/en
Publication of CO6300947A2publicationCriticalpatent/CO6300947A2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
1.- Un derivado de quinazolina de fórmula (I) en dondeo su sal farmacéuticamente aceptable.2.- Un derivado de quinazolina de fórmula (I) como se reivindica en la reivindicación 1 en donde(NRC-2694) o su sal farmacéuticamente aceptable.1. A quinazoline derivative of formula (I) wherein its pharmaceutically acceptable salt. 2. A quinazoline derivative of formula (I) as claimed in claim 1 wherein (NRC-2694) or its pharmaceutically acceptable salt. .
CO10086534A2010-07-152010-07-15
DERIVATIVES OF 6,7-DIALCOXI QUINAZOLINA USEFUL FOR THE TREATMENT OF CANCER
CO6300947A2
(en)